Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mar Drugs ; 12(9): 5035-54, 2014 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-25257788

RESUMEN

To better understand the effect of Paralytic Shellfish Toxins (PSTs) accumulation in the digestive gland of the Pacific oyster, Crassostrea gigas, we experimentally exposed individual oysters for 48 h to a PSTs producer, the dinoflagellate Alexandrium catenella. In comparison to the effect of the non-toxic Alexandrium tamarense, on the eight apoptotic related genes tested, Bax and BI.1 were significantly upregulated in oysters exposed 48 h to A. catenella. Among the five detoxification related genes tested, the expression of cytochrome P450 (CYP1A) was shown to be correlated with toxin concentration in the digestive gland of oysters exposed to the toxic dinoflagellate. Beside this, we observed a significant increase in ROS production, a decrease in caspase-3/7 activity and normal percentage of apoptotic cells in this tissue. Taken together, these results suggest a feedback mechanism, which may occur in the digestive gland where BI.1 could play a key role in preventing the induction of apoptosis by PSTs. Moreover, the expression of CYP1A, Bax and BI.1 were found to be significantly correlated to the occurrence of natural toxic events, suggesting that the expression of these genes together could be used as biomarker to assess the biological responses of oysters to stress caused by PSTs.


Asunto(s)
Apoptosis/efectos de los fármacos , Sistema Digestivo/efectos de los fármacos , Dinoflagelados/fisiología , Retroalimentación Fisiológica/efectos de los fármacos , Toxinas Marinas/toxicidad , Ostreidae/fisiología , Intoxicación por Mariscos/fisiopatología , Animales , Caspasa 3/metabolismo , Caspasa 7/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Glándulas Exocrinas/efectos de los fármacos , Glándulas Exocrinas/fisiología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Glutatión/metabolismo , Especies Reactivas de Oxígeno
2.
Abdom Radiol (NY) ; 43(3): 723-733, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28765976

RESUMEN

PURPOSE: To assess the efficacy and the safety of Glubran®2 n-butyl cyanoacrylate metacryloxysulfolane (NBCA-MS) transcatheter arterial embolization (TAE) for acute arterial bleeding from varied anatomic sites and to evaluate the predictive factors associated with clinical success and 30-day mortality. METHODS: A retrospective review of consecutive patients who underwent emergent NBCA-MS Glubran®2 TAE between July 2014 and August 2016 was conducted. Variables including age, sex, underlying malignancy, cardiovascular comorbidities, coagulation data, systolic blood pressure, and number of red blood cells units (RBC) transfused before TAE were collected. Clinical success, 30-day mortality, and complication rates were evaluated. Prognostic factors were evaluated by uni- and multivariate logistic regression analyses for clinical success, and by uni- and bivariate analyses after adjustment by bleeding sites for 30-day mortality. RESULTS: 104 patients underwent technically successful embolization with bleeding located in muscles (n = 34, 32.7%), digestive tract (n = 28, 26.9%), and viscera (n = 42, 40.4%). Clinical success rate was 76% (n = 79) and 30-day mortality rate was 21.2% (n = 22). Clinical failure was significantly associated with mortality (p < 0.0001). A number of RBC units transfused greater than or equal to 3 were associated with poorer clinical success (p = 0.025) and higher mortality (p = 0.03). Complications (n = 4, 3.8%) requiring surgery occurred only at puncture site. No ischemic complications requiring further invasive treatment occurred. Mean TAE treatment time was 4.55 min. CONCLUSIONS: NBCA-MS Glubran®2 TAE is a fast, effective, and safe treatment for acute arterial bleeding whatever the bleeding site.


Asunto(s)
Cianoacrilatos/uso terapéutico , Embolización Terapéutica/métodos , Hemorragia/terapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Angiografía , Arterias , Cianoacrilatos/efectos adversos , Embolización Terapéutica/efectos adversos , Aceite Etiodizado/uso terapéutico , Femenino , Hemorragia/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
3.
Aquat Toxicol ; 190: 133-141, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28711010

RESUMEN

Exposure of the toxin-producing dinoflagellate Alexandrium catenella (A. catenella) was previously demonstrated to cause apoptosis of hemocytes in the oyster species Crassostrea gigas. In this work, a coumarin-labeled saxitoxin appeared to spread throughout the cytoplasm of the hemocytes. PSTs, including saxitoxin, were also shown to be directly responsible for inducing apoptosis in hemocytes, a process dependent on caspase activation and independent of reactive oxygen species (ROS) production. A series of in vitro labelling and microscopy experiments revealed that STX and analogs there of induced nuclear condensation, phosphatidylserine exposure, membrane permeability, and DNA fragmentation of hemocytes. Unlike in vertebrates, gonyautoxin-5 (GTX5), which is present in high concentrations in A. catenella, was found to be more toxic than saxitoxin (STX) to oyster immune cells. Altogether, results show that PSTs produced by toxic dinoflagellates enter the cytoplasm and induce apoptosis of oyster immune cells through a caspase-dependent pathway. Because of the central role of hemocytes in mollusc immune defense, PST-induced death of hemocytes could negatively affect resistance of bivalve molluscs to microbial infection.


Asunto(s)
Apoptosis/efectos de los fármacos , Caspasas/metabolismo , Crassostrea/efectos de los fármacos , Citoplasma/efectos de los fármacos , Hemocitos/efectos de los fármacos , Saxitoxina/toxicidad , Contaminantes Químicos del Agua/toxicidad , Animales , Crassostrea/inmunología , Crassostrea/metabolismo , Citoplasma/metabolismo , Dinoflagelados/metabolismo , Hemocitos/metabolismo , Hemocitos/ultraestructura , Especies Reactivas de Oxígeno/metabolismo , Saxitoxina/metabolismo , Mariscos , Contaminantes Químicos del Agua/metabolismo
4.
Toxins (Basel) ; 8(1)2016 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-26784228

RESUMEN

The multifactorial etiology of massive Crassostrea gigas summer mortalities results from complex interactions between oysters, opportunistic pathogens and environmental factors. In a field survey conducted in 2014 in the Mediterranean Thau Lagoon (France), we evidenced that the development of the toxic dinoflagellate Alexandrium catenella, which produces paralytic shellfish toxins (PSTs), was concomitant with the accumulation of PSTs in oyster flesh and the occurrence of C. gigas mortalities. In order to investigate the possible role of toxic algae in this complex disease, we experimentally infected C. gigas oyster juveniles with Vibrio tasmaniensis strain LGP32, a strain associated with oyster summer mortalities, after oysters were exposed to Alexandrium catenella. Exposure of oysters to A. catenella significantly increased the susceptibility of oysters to V. tasmaniensis LGP32. On the contrary, exposure to the non-toxic dinoflagellate Alexandrium tamarense or to the haptophyte Tisochrysis lutea used as a foraging alga did not increase susceptibility to V. tasmaniensis LGP32. This study shows for the first time that A. catenella increases the susceptibility of Crassostrea gigas to pathogenic vibrios. Therefore, in addition to complex environmental factors explaining the mass mortalities of bivalve mollusks, feeding on neurotoxic dinoflagellates should now be considered as an environmental factor that potentially increases the severity of oyster mortality events.


Asunto(s)
Crassostrea , Dinoflagelados , Toxinas Marinas/toxicidad , Neurotoxinas/toxicidad , Vibrio/patogenicidad , Animales , Crassostrea/química , Toxinas Marinas/análisis , Neurotoxinas/análisis , Mariscos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA